Almirall (Almirall) Research & Development : $31.7 Mil (TTM As of Jun. 2023)

View and export this data going back to . Start your Free Trial

What is Almirall Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Almirall's Research & Development for the three months ended in Jun. 2023 was $6.1 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Jun. 2023 was $31.7 Mil.

Almirall Research & Development Historical Data

The historical data trend for Almirall's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Almirall Research & Development Chart

Almirall Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Research & Development

Get a 7-Day Free Trial

53.02

53.69

47.43

68.09

72.96

Almirall Quarterly Data
	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Dec22	Mar23	Jun23	Dec23
Research & Development	Get a 7-Day Free Trial															4.68	-	25.59	6.10	-

Almirall Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $31.7 Mil.

Almirall (OTCPK:LBTSF) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Almirall Research & Development Related Terms

Thank you for viewing the detailed overview of Almirall's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Almirall (Almirall) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Almirall SA (OTCPK:LBTSF) » Definitions » Research & Development

Comparable Companies

Traded in Other Exchanges

0O9B:UK ALM:Spain E2Z:Germany

Address

Ronda General Mitre 151, Barcelona, ESP, 08022

Website

http://www.almirall.es

Almirall SA is a Spain-based company engaged in development, manufacture, and selling pharmaceutical products across a range of therapeutic areas. It aims to provide treatments in areas of dermatology, respiratory, gastrointestinal, central nervous systems, and other specialties. The company operates in five segments: Sales of its own network, sales of licensees, Research and developments, Sales of Therapeutic dermatological products in the U.S., and Corporate management. The medical dermatology business in the Europe is the key driver of the company's operation. Other than Europe, the company also operates in the Americas, Asia, Africa, and Oceania through subsidiaries.